In March 2025, the company announced new plans for any direct-to-purchaser offering of its Wegovy weight loss drug. The company established a brand new pharmacy, identified as NovoCare, which might cost prospects $499 per 30 days for entry to the drug, less than 50 % the price of the drug by way of other pharmaceutical distribution networks.[fifty